LEXICON PHARMACEUTICALS, INC. (LXRX) Gross margin 2017–2025
LEXICON PHARMACEUTICALS, INC. (LXRX) gross margin by fiscal year — reported gross profit divided by reported revenue.
99.4%FY2025 · since FY2017: 88.0% → 99.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 99.4% | +9.7 pp |
| FY2024 | 89.7% | -2.6 pp |
| FY2023 | 92.3% | — |
| FY2020 | 91.8% | +1.8 pp |
| FY2019 | 90.0% | -0.6 pp |
| FY2018 | 90.6% | +2.6 pp |
| FY2017 | 88.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice